The qRT-PCR analysis demonstrated at the mRNA level that HCQ treatment significantly reduced the expression of TLR9, CD44, OCT4, and KLF4 in HCC cells (Figure 3E). The gene discussed is CD44; the disease is hepatocellular carcinoma.